The short answer
Ginger powder may change average glucose control, but added hypoglycemia with insulin glulisine has not been established. A glucose improvement in a diabetes trial does not by itself prove that interaction.
What this answer covers
Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- insulin glulisine, human
The powder study measured glucose control
An eight-week trial tested ginger powder capsules and reported lower fasting glucose and HbA1c measures. It did not supply an insulin-glulisine-specific treatment analysis.
The adverse outcome remains uncertain
Lower average glucose can be beneficial when glucose starts high. It is not the same as a documented episode of hypoglycemia. The inspected abstract does not establish a low-glucose event rate with glulisine.
Keep the preparation boundary
The trial used powder. Its dose cannot be treated as a safe threshold with insulin, and the findings do not cover every ginger extract or multi-ingredient diabetes product.
Keep meals and insulin coordinated
Discuss the exact product and dose with the diabetes team before starting or stopping it. Follow your agreed glucose-monitoring and low-glucose treatment plan. Follow Apidra’s own meal instructions; supplement spacing has no established protective effect.
Evidence and practical considerations
Side effects & toxicity
Powder efficacy trial does not establish clinical hypoglycemia during exact insulin-glulisine use.
- Exact scope
- Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols. with Insulin glulisine human RxCUI400008 IN; Apidra product and routes.
- Medication form and route
- injected insulin glulisine; oral supplement
What remains uncertain
- No exact-pair event rate or universal insulin adjustment established.
Factors that may matter: Product; Dose; Meal pattern; Other glucose-active treatments.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People with diabetes prescribed Apidra
Hypoglycemia can be severe. Niacin may decrease glucose-lowering effect. Changed glucose-active treatment may require more monitoring and clinician-directed dose review. Subcutaneous mealtime injection within15minutes before or20minutes after meal start.
How this applies: Exact insulin glulisine product and routes independently checked.
General insulin risks do not establish an herb-specific adverse-event rate. Other insulins and premixes have different action and meal instructions.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Indirect for exact insulin glulisine; source medication and supplement formulation are preserved.
No glipizide-specific regimen or low-glucose adverse-event analysis in inspected abstract. Glucose improvement is not necessarily hypoglycemia. This does not establish an exact insulin-glulisine interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact glulisine article with independently inspected Apidra label and source-specific clinical limits. | |
| Research summary published |
Article revision: b5f845304e4b5e3f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.